<DOC>
	<DOCNO>NCT02499185</DOCNO>
	<brief_summary>To validate use [ TIMP-2 ] ● [ IGFBP-7 ] predict AKI patient undergo major intra abdominal surgery .</brief_summary>
	<brief_title>Study Evaluating Novel Biomarkers AKI ( Acute Kidney Injury ) Post-operative Patients</brief_title>
	<detailed_description>A prospective pilot single center study investigate potential [ TIMP-2 ] . [ IGFBP-7 ] predict AKI ( Acute Kidney Injury ) patient undergo major abdominal surgery . The investigator measure biomarker preoperatively 4-times postoperatively start arrival PACU ( post anesthesia care unit ) .The primary endpoint study development AKI stage 2 3 within first 72 postoperative hour .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>≥ 18 year High risk patient : General Surgery AKI Risk Index Class III , IV V Major abdominal surgery Ongoing acute kidney injury Stage 2/3 History kidney transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Biomarker</keyword>
	<keyword>Intra Abdominal Surgery</keyword>
	<keyword>AKI</keyword>
</DOC>